Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (17770)	9/7/2005 1:21:29 PM
From: Biomaven	Read Replies (2) \| Respond to of 52153

patient died apparently from hypoglycemic coma, grand mal seizure, and death (the verbiage doesn't say if the same patient experienced all of these events, and the table (#69) doesn't, either; I'm making that assumption). The cause was unknown, but considered treatment related. There's a footnote to that table: The SAEs of grand mal convulsion, hypoglycemic coma, and death due to unknown cause occurred in three separate individuals. So not clear if the death was really treatment-related or not. The tighter your glucose control the more chance of hypoglycemia - it's always a tradeoff. These three events occured at a rate of .1 per 1,000 treatment-months. Peter